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Abstract Recent studies have shown that testosterone
induces relaxation of different arteries, although the mech-
anism of this action is still under debate. We investigated
the involvement of potassium channels in this mechanism.
Using standard organ bath techniques, rings of human
umbilical arteries (HUA) without endothelium were con-
tracted by serotonin (5-HT, 1 μM), histamine (10 μM) and
potassium chloride (KCl, 30 and 60 mM), and the
vasorelaxant effect of testosterone was analysed. Testoster-
one (100 μM) relaxed human umbilical arteries contracted
with 5-HT (30.1±3.2%), histamine (55.1±2.6%), KCl
30 mM (52.9±8.3%) and KCl 60 mM (54.8±6.3%).
Flutamide (10 μM), an inhibitor of classical intracellular
testosterone receptor, and glibenclamide, an ATP-sensitive
potassium-channels (KATP) inhibitor, did not influence the
testosterone relaxant effect. 4-aminopyridine, a voltage-
sensitive potassium-channels (Kv) inhibitor, decreased the
effect of testosterone on histamine- and 5-HT-contracted
arteries. Tetraethylammonium (TEA), which inhibits Kv
channels and large-conductance Ca2+-activated potassium
channels (BKCa), decreased the effect of testosterone on
KCl (60 mM)-contracted and 5-HT-contracted HUA. In
conclusion, testosterone induces relaxation of HUA, and
this effect does not appear to be mediated via a classic
intracellular testosterone receptor-dependent mechanism.
Our results suggest that this relaxation is partially mediated
by activation of BKCa and KV channels. The involvement
of these two channels in testosterone-relaxant mechanism is
dependent on the pathways activated by the contractile
agent used.
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Introduction
Human umbilical artery (HUA) is involved in fetoplacental
circulation. Endocrine and paracrine mechanisms that
regulate the contractile state of smooth muscle cells are
very important for optimum gas and nutrient exchange
between the foetus and the placenta, since the umbilical
blood vessels are not innervated. Thus, it is important to
characterise the mechanisms that regulate umbilical vessel
tone and to know which factors regulate blood flow in the
umbilical circulation. During pregnancy, there is an
increase in the amounts of some circulating sex steroid
hormones, such as androgens, which show a higher
concentration in the umbilical artery than in the umbilical
vein, indicating that these androgens are produced mainly
in the foetal compartment (Pasqualini 2005).
Gender differences in the incidence of cardiovascular
health problems have been attributed to different sex
hormonal patterns found in women and men. Recent studies
illustrate that testosterone (Tes) has beneficial cardiovascu-
lar effects, and several epidemiological studies also indi-
cated that patients with cardiovascular diseases have low
levels of Tes (Alexandersen et al. 1996; English et al.
2000a, b, c; Tammaro et al. 2004). Moreover, hypotestos-
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teronemia was associated with an atherogenic lipid profile,
high fibrinogen levels, an increase in insulin resistance,
hyperinsulinemia and higher systolic and diastolic blood
pressure levels (English et al. 2000a; Pinthus et al. 2006).
However, an increase in maternal serum androgen concen-
tration during pregnancy was also associated with pre-
eclampsia (Salamalekis et al. 2006) and pregnancy-induced
hypertension (Gerulewicz-Vannini et al. 2006).
Some recent studies have demonstrated that Tes acts as
direct vasodilator in a variety of species and blood vessels
(Orshal and Khalil 2004), including human arteries (Malkin
et al. 2006; Yildiz et al. 2005). The rapid vascular effects of
Tes suggest the involvement of mechanisms related to
membrane receptors and independent of the classic ge-
nomic pathway (Orshal and Khalil 2004).
The participation of the endothelium in Tes vascular-
relaxant mechanism has also been analysed by different
authors. Yue et al. indicated that Tes induces endothelium-
independent relaxation in isolated rabbit coronary artery
and aorta, which is mediated neither by prostaglandin I2 nor
cyclic GMP (Yue et al. 1995). Tes-induced relaxation of
porcine coronary arteries was associated with accumulation
of cGMP by an endothelium-independent mechanism
(Deenadayalu et al. 2001). However, other works showed
that removal of the endothelium reduces the Tes relaxant
effect in aorta (Ding and Stallone 2001) and mesenteric
artery (Tep-areenan et al. 2002; Tep-areenan et al. 2003) of
rats.
The mechanism of Tes in smooth muscle cells is still
unclear. Some authors suggested that the relaxant effect of
Tes is induced by a blockade of smooth muscle calcium
channels in rat aorta (Perusquia and Villalon 1999), pig
coronary artery (Crews and Khalil 1999; Murphy and
Khalil 1999) and rat pulmonary artery (Jones et al. 2002).
More specifically, Perusquia et al. suggested that inhibition
of receptor-operated calcium channels in rat aorta might be
the mechanism that induces androgen-associated relaxing
effects (Perusquia et al. 1996). Recently, the inhibition of
voltage-dependent calcium channels by Tes was demon-
strated by authors working with rat pulmonary artery (Jones
et al. 2002) and with A7r5 cells from rat aorta (Hall et al.
2006). In contrast, several authors showed that Tes-induced
relaxant effect is due to activation of smooth muscle
potassium channels in rat aorta (Ding and Stallone 2001;
Honda et al. 1999), pig coronary artery (Deenadayalu et al.
2001) and rabbit coronary artery (Yue et al. 1995). The
activation of several potassium channel types was involved
in Tes-associated relaxant effect in different arteries, such as
KATP channels in dog coronary artery (Chou et al. 1996)
and rat aorta (Honda et al. 1999) and BKCa channels in
human internal mammary artery (Yildiz et al. 2005). When
proposing a vasodilatory mechanism for Tes, the discrep-
ancy between these results is evident, but differences in
species and vascular preparations used have likely contrib-
uted to these discrepancies.
In our study, we focus on the endothelium-independent
vascular mechanisms of Tes-induced vasorelaxation in
HUA when these arteries are contracted by depolarisation
with KCl, or by histamine (His) and serotonin (5-HT)
receptor activation. The involvement of the classic intra-
cellular Tes receptor and different potassium channel types
on the Tes relaxant effect was analysed.
Methods
Tissue preparation
Umbilical cord pieces of 3–7 cm were obtained from
normal term pregnancies with the consent of the donor
mothers. All procedures carried out with these samples
were approved by the Ethics Committee of Centro
Hospitalar da Cova da Beira EPE. The umbilical cord
samples were collected in sterile physiological saline
solution (PSS) [composition (mM): NaCl 110, CaCl2 0.15,
KCl 5, MgCl2 2, HEPES 10, NaHCO3 10, KH2PO4 0.5,
NaH2PO4 0.5, glucose 10, EDTA 0.49]. In order to avoid
contamination and tissue degradation, penicillin (5 U/ml),
streptomycin (5 μg/ml), amphotericin B (12.5 ng/ml) and
antiproteases (leupeptine 0.45 mg/l, benzamidine 26 mg/l)
and trypsin inhibitor (10 mg/l) were added to the PSS
solution. Umbilical artery rings of 3–5 mm were isolated
from the surrounding connective tissue. Vascular endothe-
lium was mechanically removed by gentle rubbing with a
cotton bud introduced through the arterial lumen.
Artery tension recordings
The HUA rings were placed in an organ bath (LE01.004,
Letica) containing Krebs-bicarbonate solution (composition
in mM: NaCl 119, KCl 5.0, NaHCO3 25, KH2PO4 1.2,
CaCl2 0.5, MgSO4 1.2, EDTA 0.03, glucose 11) at 37°C
and continuously gassed with carbogen. The artery rings
were suspended between two parallel stainless steel wires
and tension measurement was performed using isometric
transducers (TRI201, Panlab SA, Spain), amplifier
(ML118/D Quad Bridge, ADInstruments), interface Power-
Lab/4SP (ML750, ADInstruments) and computerised sys-
tem with Chart5 PowerLab software (ADInstruments).
During the resting periods, the organ bath solution was
changed every 15 min. Initially, the rings were equilibrated
for 60 min until a resting tension of 1.5g was achieved.
After this, the rings were challenged with 5-HT (1 μM) to
test their viability. Rings that induced contraction of less
than 1 g when challenged with 5-HT were excluded from
the study. Afterwards, HUA rings were contracted using
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KCl (30 and 60 mM), His (10 μM) or 5-HT (1 μM), and
vasorelaxation induced by Tes (1–100 μM) on these
contractions was analysed. In some cases, the involvement
of classical Tes receptors was examined using flutamide
(Flu; 10 μM), an antagonist of these receptors. To
determine the role of potassium-channels activation in
Tes-induced vasorelaxation, several inhibitors were used:
tetraethylammonium (TEA; 1 mM), an inhibitor of large-
conductance Ca2+-activated (BKCa) and voltage-sensitive
(Kv) potassium channels; glibenclamide (Gli; 10 μM), an
ATP-sensitive potassium-channel (KATP) inhibitor; and 4-
aminopyridine (4-AP; 1 mM), an inhibitor of voltage-
sensitive potassium (KV) channels.
Drugs and chemicals
All drugs and chemicals were purchased from Sigma-
Aldrich Química (Sintra, Portugal), except 4-AP, which was
purchased from Biogen Cientifica. (Madrid, Spain). Testos-
terone and Flu were initially dissolved in dimethyl
sulfoxide (DMSO) and ethanol respectively, and final
solutions were obtained by dilution with distilled water.
The final concentration of both organic solvents in the
organ bath did not exceed 0.1%. Histamine, 5-HT, Gli, 4-
AP and TEA were dissolved in distilled water.
Statistical analysis
Statistical treatment of data was performed using the
SigmaStat Statistical Analysis System, version 1.00
(1992). Results are expressed as mean ± SEM of n
experiments. Relaxant Tes effects are given as percentage
of decrease in the contraction induced by KCl, His or 5-HT.
Statistical significance between two groups was analysed
using Student’s t-test. Comparison among multiple groups
was analysed by using a one-way ANOVA followed by
Tukey test or Dunnet’s post-hoc tests to determine
significant differences among the means. Probability levels
lower than 5% were considered significant (P<0.05).
Results
Effect of Tes on contracted HUA
The HUA rings without endothelium were exposed to
different receptor agonists and to depolarisation to analyse
their sensitivity. Although noradrenaline (1 μM) and
angiotensin II (1 μM) did not induce significant effects
(data not shown), 5-HT (1 μM) and His (10 μM) elicited
maximum contractile effects of 1,648.4±67.2 (n=90) and
1,296.8±57.3 mg (n=86) respectively, which were signif-
icantly different (P<0.05, one-way ANOVA with Tukey
post-hoc test). Different degrees of depolarisation, by KCl
30 and 60 mM, induced dissimilar degrees of maximum
contraction: 1,009.9±87.0 mg (n=13) and 1,413.9±62.2 mg
(n=59) respectively (P<0.05, one-way ANOVA with
Tukey post-hoc test). These last three contractile agents
were used as previous stimuli to analyse the effect of Tes.
In general, Tes induced concentration-dependent vaso-
relaxations of HUA ring contracted with either 5-HT, His or
KCl (Figs. 1 and 2a), and the time to reach the effect of
each concentration was between 2 and 12 min. DMSO, the
vehicle used to dissolve Tes, did not have a significant
relaxant effect on contracted arteries at the concentrations
used. As shown in Fig. 1, the maximum relaxation induced
by Tes (100 μM) was similar in arteries treated with His or
KCl 30 and 60 mM: 55.8±5.7%, 52.9±8.3% and 53.2±
6.3% respectively (P>0.05). The maximum Tes effect on 5-
HT-contracted arteries was significantly lower (30.1±3.2%)
than that observed with His or KCl (P<0.05). However, the
effect of Tes at lower concentrations (1–30 μM) was
significantly greater in arteries contracted by His than in
5-HT- or KCl-stimulated arteries (P<0.05). In fact, Fig. 1
shows that Tes concentrations of 1 and 10 μM induced
significant relaxation only in His-stimulated arteries (P<
0.05 and P<0.01 respectively). These results also show that
the relaxant effects of Tes are more prominent in His-
contracted HUA, and the lowest Tes effects were observed
when the contractile agent used was 5-HT. The relaxations
induced by the different concentrations of Tes (1 μM–
100 μM) on HUA contracted by KCl 30 and 60 mM were
similar (P>0.05).
Fig. 1 Cumulative concentration-relaxation curves of testosterone (1–
100 μM) in endothelium-denuded HUA rings contracted with
serotonin (5-HT; 1 μM), histamine (His; 1 μM), KCl (30 mM) or
KCl (60 mM). Each point represents the mean value and the vertical
lines indicate SEM of at least five experiments. *P<0.05 versus
control performed with vehicle, Student’s t-test. Different letters (a, b)
indicate significant differences (P<0.05, one-way ANOVA with
Tukey post-hoc test) between the effects induced by a concentration
of testosterone on arteries contracted with different agents
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Flutamide, an inhibitor of the Tes classical intracellular
receptor, was used to analyse the involvement of this
receptor in the relaxing effect mediated by Tes. Flutamide
alone did not induce a significant relaxation of contractions
induced by 5-HT, His or KCl 60 mM (Table 1). As shown
in Fig. 3, flutamide 10 μM did not significantly modify the
Tes-associated relaxant effect on either 5-HT, His or KCl
(60 mM) contracted arteries (P>0.05). Ethanol, the vehicle
used to dissolve flutamide, did not have any effect at the
concentrations used (data not shown). These data indicate
that the effects of Tes are mediated by mechanisms other
than activation of the classical intracellular Tes receptor.
The role of potassium channels in Tes-induced
vasorelaxation
The effects of three potassium channel inhibitors (Gli, 4-
AP, and TEA) were investigated to analyse the involvement
of these channels in the Tes-associated relaxant mechanism.
Initially, after contraction by the different agents, HUA
were exposed for 15 min to Gli, 4-AP and TEA, either
together or separately, and these inhibitors did not have a
significant effect on the contraction induced by either 5-HT,
His or KCl 60 mM (Fig. 2b, Table 1).
As shown in Fig. 4, independently of the contractile
stimuli, incubation with Gli, 4-AP and TEA together
significantly reduced the maximum (100 μM) Tes-associated
relaxing effects. However this reduction was different
depending on the contractile agent.
The application of Gli (10 μM), which inhibits ATP-
sensitive potassium channels (KATP), did not significantly
Table 1 Effect (%; mean ± SEM) of flutamide (Flu; 10 μM),
glibenclamide (Gli; 10 μM), 4-aminopyridine (4-AP; 1 mM), and
tetraethylammonium (TEA; 1 mM) on the contractions induced by
serotonin (5-HT; 1 μM), histamine (His; 1 μM) or KCl (60 mM)
5-HT (%) His (%) KCl (%)
Flu −0.7±1.3 (n=16) −1.4±1.9 (n =12) 0.4±2.8 (n=8)
Gli 0.8±1.0 (n=36) −1.6±0.8 (n=18) 1.2±1.0 (n=29)
4-AP 0.3±1.1 (n=10) −1.1±1.2 (n=5) 0.0±1.8 (n=8)
TEA −0.4±0.7 (n=10) 0.4±2.9 (n=9) 0.3±3.6 (n=9)
Gli+4−
AP+TEA
2.3±1.9 (n=5) −2.4±0.6 (n=5) −0.2±1.2 (n=8)
Fig. 2 Original tracing of KCl
(60 mM)-contracted human um-
bilical artery rings showing the
relaxation induced by different
concentrations (1–100 μM) of
testosterone (Tes) in a absence
and b presence of tetraethylam-
monium (TEA)
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reduce the effects of Tes on 5-HT-, His- or KCl-contracted
arteries (P>0.05).
With regards to the role of the voltage-sensitive channels
(KV), 4-AP (1 mM) reduced the Tes-associated effect in 5-
HT- and His-contracted arteries (P<0.05). However, this
drug did not significantly reduce the Tes-induced relaxation
of KCl-contracted arteries as shown in Fig. 4 (P>0.05).
Fig. 4 Effect of the potassium channel inhibitors glibenclamide (Gli;
10 μM), 4-aminopyridine (4-AP; 1 mM), and tetraethylammonium
(TEA; 1 mM) on maximum testosterone relaxant effect in HUA
contracted with a 1 μM serotonin (5-HT), b 1 μM histamine (His) and
c 60 mM KCl. Data are expressed as percent of inhibition on the
contractile effects, the bars represent the mean and the lines the SEM
of the number of experiments indicated near the bars. *P<0.05 versus
testosterone effects in absence of any channel inhibitor, one-way
ANOVA with Dunnet’s post-hoc test
Fig. 3 Testosterone relaxing effect on contracted HUA in absence
(open symbols) and presence (closed symbols) of flutamide 10 μM.
Data are expressed as percentage of relaxation on arteries contracted
with a 1 μM serotonin (5-HT), b 1 μM histamine (His) and c 60 mM
KCl. Each point represents the mean and the vertical lines the SEM of
at least five experiments
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TEA, an inhibitor of BKCa and Kv channels, signifi-
cantly reduced the relaxant effect of Tes on 5-HT- and
KCl-stimulated arteries, but its action to reduce the effect
of Tes was not significant in His-contracted arteries
(Figs. 2b and 4).
Discussion
As expected and in accordance with other authors (Quan et
al. 2003), our results show that the contraction induced by
KCl (30 mM) was smaller than that induced by KCl
(60 mM) because the depolarisation degree is different.
Maximum contractions caused by 5-HT and KCl (60 mM)
in HUA are not significantly different. This has already
been reported by some authors (Leung et al. 2006),
although other investigators indicated that 5-HT-induced
contraction is greater than that produced by KCl depolar-
isation (Tufan et al. 2003). However, the tension produced
by His was lower than that induced by 5-HT, results that are
in agreement with those of Quan et al. (2003).
The different mechanisms implicated in the contractile
effect of these agents could explain the results. Vascular
contraction induced by KCl is mainly due to the influx of
extracellular calcium via voltage-dependent calcium chan-
nels (Tufan et al. 2003), but Kv-channel inactivation at high
potassium concentrations (60 mM) was also demonstrated
in some blood vessels (Jarajapu et al. 2006). The contractile
effects of 5-HT in denuded HUA are due to the activation
of the receptors 5-HT1B and 5-HT2A (Lovren et al. 1999).
The activation of 5-HT1B receptor inhibits adenylyl cyclase,
and the 5-HT2A-receptor activation stimulates phospholi-
pase C, thereby increasing inositol 1,4,5-triphosphate (IP3)
levels (Pauwels 2000; Steinert et al. 2002; Tufan et al.
2003). Recently, using patch-clamp techniques, some
authors demonstrated that 5-HT2A-receptor activation
decreases Kv-channel activity in cells of rat pulmonary
(Cogolludo et al. 2006) and mesenteric (Bae et al. 2006)
arteries. The 5-HT7 receptors were also implicated in the
endothelium-independent vasorelaxation of several blood
vessels because their activation stimulates adenylyl cyclase
(Jahnichen et al. 2005; Terron and Falcon-Neri 1999).
However, expression of these receptors was not demon-
strated in HUA.
In the case of His, activation of H1 receptors in HUA
smooth muscle induces contraction by activation of
phospholipase C and increase in IP3 levels (Hawley et al.
1995). The expression of H2 receptors in human umbilical
smooth muscle was also reported by Schneider et al.
(Schneider et al. 2004). The activation of this receptor
stimulates adenylyl cyclase activity producing an increase
in cyclic AMP and relaxation. Jarajapu et al. suggested that
vasodilatation of rat cerebral resistance arteries by H2-
receptor activation may be mediated by stimulation of KV
channels (Jarajapu et al. 2006). Thus, the lower maximum
contractile effects of His, when compared with those of 5-
HT and KCl, may be due to the activation of different
receptor types and pathways. Histamine seems to activate
H2 receptors mediating vasorelaxation that could decrease
the contractile effect induced by H1 activation, even if the
latter effect is predominant. On the other hand, H1- and H2-
receptor activation by His seems to stimulate potassium
channels whereas 5-HT and KCl have the opposite actions
and this could explain the greater contractile effect of 5-HT
and KCl on HUA.
Our results show that Tes induces a concentration-
dependent relaxation of denuded HUA rings contracted
with either 5-HT, His or KCl (30 and 60 mM). The
maximum relaxation was obtained at 100 μM of Tes and
was similar in HUA contracted by His and KCl (30 and
60 mM). Lower maximum relaxation was obtained in 5-
HT-contracted arteries. These results differ from those
obtained by Fausset et al. that showed a much lower
degree of relaxation (9.2%) in KCl-contracted intact HUA
(Fausett et al. 1999). The maximum Tes-associated effects
described in the literature for other arteries contracted with
KCl are diverse, but there are no data regarding His- and 5-
HT-contracted arteries. Despite the maximum Tes-associat-
ed effect, the relaxation induced by lower concentrations of
Tes (1–30 μM) is significantly greater for His-contracted
arteries. These different effects, which depend upon the
contractile agent used, could give some indications as to
what mechanisms might be involved in Tes-induced
relaxation.
One of the pathways implicated in 5-HT contractility is
the inhibition of adenylyl cyclase, whereas the phospholy-
pase C pathway is implicated in both His and 5-HT
contractile effects. Could the inhibition of adenylyl cyclase
by 5-HT be responsible for the lower effect of Tes on the
arteries contracted by this agent? There are no data in the
literature to support the hypothesis that Tes-associated
effects are mediated by adenylyl cyclase activation. On
the other hand, KCl induces depolarisation of the smooth
muscle cell membrane by opening calcium channels. Could
the cell membrane hyperpolarisation be implicated in the
Tes mechanism for induction of vascular relaxation? Some
authors suggested that Tes stimulates potassium channels in
rat aorta (Honda et al. 1999) and also in rabbit (Won et al.
2003) and pig (Deenadayalu et al. 2001) coronary arteries.
Other authors demonstrated a blockage of calcium channels
by Tes in the aorta (Perusquia et al. 1996) and coronary
artery (Jones et al. 2004) of rats.
As mentioned above, some authors showed that inhibi-
tion of potassium channels is induced by 5-HT (Bae et al.
2006; Cogolludo et al. 2006) and KCl (Jarajapu et al.
2006), whereas theses channels are stimulated by His
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(Jarajapu et al. 2006). Could the effect of contractile agents
on potassium channels be responsible for the different
actions of Tes on contractions induced by each one? If the
Tes-associated vasorelaxant mechanism is due to the
activation of potassium channels, the effect of Tes on 5-
HT- and KCl-induced contractions will be lower than that
on His-induced contractions. If the vasorelaxant mechanism
of Tes is only due to blockage of calcium channels, the
effect of Tes on 5-HT- and KCl-induced contractions will
be similar. In this regard, our results could indicate that Tes
relaxes by activating potassium channels, in agreement with
the results in different blood vessels obtained by other
authors (Deenadayalu et al. 2001; Honda et al. 1999; Won
et al. 2003).
On the other hand, high extracellular KCl reduces the
chemical gradient for K efflux and could reduce or avoid
the effect of Tes on KCl contraction, which will be lower
than that on agonist-contracted arteries. In accordance with
this, some investigators did not obtain Tes-induced relax-
ation on KCl-contracted arteries (Fausett et al. 1999; Tep-
areenan et al. 2002). However, other authors had reliable
maximum relaxation with KCl-induced contractions, name-
ly 50% in rat aorta (Ding and Stallone 2001), 40% in rabbit
coronary artery (Yue et al. 1995), 80% in human subcuta-
neous artery (Malkin et al. 2006) and 100% in rat coronary
artery (Jones et al. 2004). Our results show identical
vasodilatation induced by different Tes concentrations (1–
100 μM) when two concentrations of KCl (30 and 60 mM)
were used to pre-constrict HUA. Jones et al. observed the
same Tes effect in rat coronary artery using various
concentrations of KCl to pre-constrict the vessels (Jones
et al. 2004). These observations suggest that extracellular
potassium concentration and the depolarisation degree have
no influence on the vasodilator efficacy of Tes. Regardless
of the mechanism, it is clear that testosterone modulates the
excitability of vascular smooth muscle, and our data
provide evidence that this steroid opens potassium channels
in HUA. Thus, our study focused on the role of different
types of potassium channels in the vasorelaxant mechanism
of Tes.
Testosterone is a sex steroid hormone, and the interac-
tion of these hormones with intracellular receptors has long
been known to stimulate genomic effects that could
influence vascular cell growth and proliferation. Con-
cerning the non-genomic effects, some studies indicated
the participation of the intracellular receptor and others
suggested that the effects are independent of this receptor
(Falkenstein et al. 2000). Our findings show that Tes-
induced vasorelaxation was not inhibited by a Tes intracel-
lular receptor antagonist, suggesting that the vasorelaxation
is mediated via another receptor or pathway. These results
are in agreement with previous studies in coronary artery
and aorta of rabbit (Yue et al. 1995) and in mesenteric
artery (Tep-areenan et al. 2002) and aorta (Tep-areenan et
al. 2003) of rat, which also showed that Tes-induced
vasorelaxation is unaffected by flutamide. In contrast,
Murphy et al. showed that Tes-associated relaxant effect
in pig coronary artery is inhibited by flutamide (Murphy
and Khalil 1999). In order to explain these differences,
some authors suggested that species and/or regional differ-
ences may involve differential distributions of steroid
hormone receptors (Tep-areenan et al. 2002; Tep-areenan
et al. 2003). A large number of studies have reported Tes-
induced vasorelaxation in animal (Crews and Khalil 1999;
Deenadayalu et al. 2001; Perusquia and Villalon 1999;
Perusquia et al. 1996; Yue et al. 1995) and human arteries
(Yildiz et al. 2005) without endothelium. Our results in
HUA confirm that Tes induces vasorelaxation independent-
ly of the endothelium, and this effect is not mediated via a
classic intracellular receptor-dependent mechanism.
The inhibitors of potassium channels did not have any
effect on 5-HT-, His- or KCl (60 mM)-contracted arteries.
However, incubation with Gli, 4-AP and TEA together
reduced the Tes-induced (100 μM) relaxation effects for all
contractile agents used. These results agree with a previous
study in rabbit coronary arteries and thoracic aorta, where
barium chloride, an unspecific inhibitor of potassium
channels, reduced the Tes-associated relaxation effects
(Yue et al. 1995). These findings strongly suggest that
opening potassium channels results in hyperpolarisation of
the vascular cell membranes and closing of the voltage-
dependent calcium channels. In this regard, some authors
suggested that Tes inhibits calcium influx through calcium
channels in different blood vessels (Crews and Khalil 1999;
Jones et al. 2002; Murphy and Khalil 1999; Perusquia and
Villalon 1999; Scragg et al. 2004). However, as potassium-
channel inhibition did not completely abolish this relaxa-
tion, other mechanisms are presumably involved.
The Tes-induced relaxation on 5-HT-associated contrac-
tions was significantly inhibited by KV and BKCa channel
inhibitors, suggesting the participation of these channels in
Tes relaxant mechanism. Similar data were obtained by Yue
et al. in prostaglandin F2alpha-contracted rabbit coronary
artery (Yue et al. 1995).
Testosterone-induced relaxation on His-associated con-
traction was principally inhibited by 4-AP, and the effect
observed with this selective blocker is similar to the effect
obtained by the application of all blockers together,
indicating that Tes may cause vasorelaxation mainly via
Kv in His-contracted HUA. The involvement of KV-
channel activation in Tes-induced vasorelaxation of rat
aorta contracted with phenylephrine was also suggested by
Ding and Stallone (2001).
The effect of Tes on KCl-induced contraction was
significantly inhibited by TEA, but not by Gli or 4-AP,
indicating that Tes-associated vasorelaxation is mainly
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caused by BKCa activation in HUA contracted with KCl. In
agreement with this data, Yildiz et al. demonstrated that
TEA inhibits vasorelaxation induced by Tes in internal
mammary artery rings contracted with KCl (Yildiz et al.
2005). Some authors also suggested that Tes opens BKCa
in the rat mesenteric arterial bed (Tep-areenan et al. 2002)
and rat aorta (Tep-areenan et al. 2003), inducing relaxation
of KCl-associated contractions. Moreover, Deenadayalu et al.
demonstrated by patch-clamp studies that testosterone opens
BKCa channels in porcine coronary smooth muscle cells,
and also suggested that these channels are activated by a
smooth muscle cell source of cGMP (Deenadayalu et al.
2001). Further investigations are needed to analyse the
role of cyclic nucleotides on Tes-associated vascular
effects.
Thus, our results indicate that the activation of KV and
BKCa channels is involved in the relaxant effects of Tes,
and the participation of these two channels was dependent
on the contractile agent used. The present data indicate that
the effects of Tes on KCl-induced contractions are due to
BKCa but not to KV activation. Lack of relevance of KV in
this case might be explained by the effects of KCl on
vascular smooth muscle. Jarajapu et al. showed that Kv
channels are inactivated at high concentrations of KCl
(60 mM) (Jarajapu et al. 2006), in which case the KV open
probability induced by Tes would be lower and the
contribution of these channels towards the Tes-associated
relaxant effect on KCl-contracted HUA would be not
significant. Some authors also demonstrated that 5-HT
decreases Kv current in smooth muscle cells (Bae et al.
2006; Cogolludo et al. 2006). However our results in 5-HT-
contracted arteries show that activation of both KV and
BKCa channels is involved in Tes vasorelaxation. Maybe
Tes can reverse the decrease in activity induced by 5-HT on
these channels and is unable to reverse the KV-channels
inactivation induced by KCl. In contrast, Jarajapu et al.
suggested a functional coupling of H2 receptors to KV
channels that activates these channels (Jarajapu et al. 2006).
As previously mentioned, we associated the effect of
contractile agents on potassium channels with the greater
Tes-induced relaxation on His contraction when compared
with 5-HT or KCl contractile actions. Our data show that
activation of KV is involved in Tes-induced relaxation in
HUA contracted by His. Probably, after exposure to His, a
further activation of KV by Tes is responsible for a greater
relaxation of HUA obtained with this agonist. Nevertheless,
the reason why BKCa channels are not significantly
involved in Tes vasorelaxation of HUA contracted by His
remains unknown, and further research using electrophys-
iological techniques needs to be performed.
In summary, the primary goal of this study was to
determine the effects of testosterone on HUA without
endothelium. We have shown that Tes induces vasorelaxation
of these arteries and our results suggest that this effect is not
mediated via the classic intracellular Tes-receptor-dependent
mechanism. This relaxation appears to be partially mediated
by activation of BKCa- and KV-channel activation. The
involvement of these two channels in the Tes relaxant
mechanism is dependent on the pathways activated by the
contractile agent used. Further investigations are needed to
identify the signalling mechanisms that couple testosterone
receptor activation to potassium channel stimulation.
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